QUOTE AND NEWS
Forbes  11 hrs ago  Comment 
Analysts are looking for decreased profit for Sanofi when the company reports its results for the fourth quarter on Thursday, February 5, 2015. Sanofi reported profit of 93 cents a year ago, but the consensus estimate calls for earnings per share...
FiercePharma  Feb 3  Comment 
Sanofi and MannKind heralded the launch of Afrezza today, as their inhaled insulin hit store shelves in the U.S. For MannKind, it's a vindication after years of development setbacks. For Sanofi, it's a chance to show that it can broaden its base...
FierceBiotech  Feb 3  Comment 
Kees Been has banked the $20 million round needed to move a bold new development program for delaying or preventing Parkinson's toward the clinic. And the veteran biotech CEO at the helm of Lysosomal Therapeutics Inc. is moving forward with a...
FiercePharma  Jan 30  Comment 
So far, Sanofi has come up empty-handed in its hunt for a CEO to replace the ousted Chris Viehbacher. And the mystery surrounding his firing may have something to do with it.
guardian.co.uk  Jan 30  Comment 
Analysts say group could open more coffee shops and raise prices It may sometimes seem the UK is awash with coffee shops, but analysts believe there is plenty of room for more, which is good news for Costa Coffee owner Whitbread. In a buy note...
The Hindu Business Line  Jan 30  Comment 
Sanofi, the French healthcare giant will invest Rs 90 crore into Apollo Sugar Clinics Limitd (ASCL), a diabetes care focussed chain of Apollo Hospitals Group. Sanofi-Synthelabo (India) Li...
Yahoo  Jan 30  Comment 
Barring a last-minute breakthrough, drugs firm Sanofi's Chairman Serge Weinberg may have to acknowledge in his results presentation next week that the hunt for a new chief executive is not going well. The manner of Chris Viehbacher's shock...
FierceBiotech  Jan 26  Comment 
Amgen just lost a key regulatory race. Armed with a handy FDA shortcut voucher, Regeneron and its Big Pharma partner Sanofi announced today that the agency has accepted their application for the powerful new PCSK9 cholesterol drug alirocumab and...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki